Last updated: 2026-09-05 18:51:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
MiMedx Group, Inc. (MDXG) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $4,57, with a market capitalisation of $663,21M and a P/E ratio of 103,50. Over the past 52 weeks, its price has ranged from $3,03 to $7,97. This page covers its latest market performance, valuation, price trends and company information.
$663,21M | |
$4,41 | |
$18,25 | |
$1,81 | |
$4,43 | |
530,22K | |
-- | |
103,50 | |
$7,97 | |
$3,03 | |
-- | |
-- |
MiMedx Group, Inc. (MDXG) last closed at $4,43 as of 2026-09-04 23:31:00, unchanged from the previous close of $4,43.
During the latest regular trading session, MDXG traded between $1,81 and $18,25, with a volume of 530,22K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, MiMedx Group, Inc. (MDXG) moved from $4,49 to $4,57, representing a gain of 1,67% ($0,08).
The stock traded between $4,41 and $4,59 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 914,18 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 31,1%
MDXG is currently trading at $4,57, placing it 31,1% of the way from its 52-week low of $3,03 to its 52-week high of $7,97. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 808 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of MiMedx Group, Inc. (MDXG) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.